The intrinsic value of Kura Oncology, Inc. is calculated using the Discounted Cash Flow (DCF) model, indicating a fair value estimate lower than the analyst price target. The DCF method considers future cash flows and growth rates to determine the company's value.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing